Showing results (121-130 of 163) with videos related to
Sort By:
Pageof 17
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2025
Outcomes following exploratory surgery without subsequent resection in perihilar cholangiocarcinoma: A nationwide analysisJulien A Luyten, Lydia G van der Geest, Steven W M Olde Damink, et al.Mbio|May 20, 2025
Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicityLars E Hillege, Kai R Trepka, Benjamin G H Guthrie, et al.Cancer Medicine|October 27, 2020
Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort studyAnouk E J Latenstein, Willemieke P M Dijksterhuis, Tara M Mackay, et al.Pain|July 6, 2026
Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort studyAniek E Van Diepen, Merlijn U J E Graus, Simone Augustinus, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 14, 2026
Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysisThijmen H T Broekman, Simone Augustinus, Nanske Biesma, et al.European Journal of Cancer (Oxford, England : 1990)|October 23, 2025
Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort studyGaby J Strijk, Jelle C van Dongen, Willem de Koning, et al.Journal of Cardiovascular Translational Research|March 14, 2025
Human Cardiac Microtissues Display Improved Engraftment and Survival in a Porcine Model of Myocardial InfarctionEvelyne Demkes, Aina Cervera-Barea, Patricia Ebner-Peking, et al.International Journal of Cancer|December 22, 2021
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinomaEvelien J M de Jong, Quisette P Janssen, Tessa F A Simons, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 TrialTanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.Health and Quality of Life Outcomes|December 24, 2025
Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experimentMarjolein F Lansbergen, Ian P Smith, Evelien N van Alphen, et al.Pageof 17